Pharmacy- Page 178

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

License to Market Kremezin(R) (drug for chronic renal failure) in Japan

The FINANCIAL -- KUREHA CORPORATION (Head office: Chuo-ku, Tokyo; President & CEO: Takao Iwasaki; hereinafter, "KUREHA") and Mitsubishi Tanabe Pharma Corporation (Head office: Chuo-ku, Osaka; President & CEO: Michihiro Tsuchiya; hereinafter, "Mitsubishi Tanabe") have entered into an agreement ("the Agreement"), effective on

by The FINANCIAL

October 5, 2009

1 min read

Pharmacy

Sandoz launches somatropin increasing access to key medicines in second largest global market

The FINANCIAL -- Sandoz on October 5 announced the launch of its recombinant human growth hormone somatropin in Japan, the first-ever biosimilar to be approved and launched on the world's second largest pharmaceutical market.

by The FINANCIAL

October 5, 2009

1 min read

Pharmacy

Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA

The FINANCIAL -- Merck & Co., Inc. announced on September 28 that the Company has entered into an exclusive agreement with CSL Biotherapies, a subsidiary of CSL Limited, to market and distribute AFLURIA (Influenza Virus Vaccine), CSL's seasonal influenza (flu) vaccine, in the

by The FINANCIAL

September 28, 2009

1 min read

Pharmacy

Johnson & Johnson Buys Crucell shares for 302 million euros

The FINANCIAL -- U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in Dutch biotechnology company Crucell NV for euro301.8 million as part of a deal to collaborate on the treatment and prevention of influenza.

by The FINANCIAL

September 28, 2009

2 mins read

Pharmacy

UCB and AstraZeneca form alliance for the commercialization of Cimzia in Brazil

The FINANCIAL -- UCB and AstraZeneca announced on September 28 that they have entered into a partnership to register and commercialize UCB's PEGylated anti-TNF alpha drug Cimzia (certolizumab pegol) in Brazil. The drug is to be registered for the treatment of rheumatoid arthritis and

by The FINANCIAL

September 28, 2009

1 min read

Pharmacy

Abbott to Acquire Solvay Pharmaceuticals Business

The FINANCIAL -- Abbott on September 28 announced a definitive agreement with the Solvay Group for Abbott to acquire Solvay's pharmaceuticals business for EUR 4.5 billion ($6.6 billion) in cash, providing Abbott with a large and complementary portfolio of pharmaceutical products and a significant

by The FINANCIAL

September 28, 2009

2 mins read

Pharmacy

First blood glucose designed especially for children

The FINANCIAL -- At the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) Bayer Diabetes Care introduced DIDGET, the first and only blood glucose meter for kids with diabetes that connects directly to Nintendo DS and DS

by The FINANCIAL

September 28, 2009

2 mins read

Pharmacy

First blood glucose monitor with Plug & Play Diabetes Management Software

The FINANCIAL -- At the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) Bayer Diabetes Care announced clearance to market the CONTOUR USB meter in Europe and in the U.S.A.

by The FINANCIAL

September 28, 2009

1 min read

Pharmacy

Lilly Receives 100 Percent Rating on Corporate Equality Index Survey

The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) has been given a 100 percent rating on the Human Rights Campaign's (HRC) Corporate Equality Index for 2010. This is the fourth consecutive year Lilly is recognized as one of the Best Places

by The FINANCIAL

September 21, 2009

1 min read

Pharmacy

Amgen Reports Results Of Trial Of Cancer Treatment

The FINANCIAL -- Amgen (Nasdaq: AMGN) on September 21 announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors

by The FINANCIAL

September 21, 2009

2 mins read